First month free — Unlimited access to SIJ markets, analysis & insights.
The latest health coverage, expert analysis, and breaking developments from around the world.
Moderna and Merck reported that their personalized mRNA cancer vaccine reduced tumor recurrence by 67% in advanced melanoma patients during a pivotal Phase 3 trial, potentially opening a new era in oncology treatment.
Dr. Amanda Foster·13h ago
The World Health Organization activated its highest alert level after a new mpox variant showed increased transmissibility across 14 countries. Health agencies worldwide are accelerating vaccine distribution and surveillance protocols.
Dr. Amanda Foster·22h ago
Novo Nordisk unveiled CagriSema, a combination therapy that showed 25.4% average weight loss in Phase 3 trials, surpassing current GLP-1 drugs. The company's market capitalization briefly exceeded $700 billion on the announcement.
Dr. Amanda Foster·23h ago
Ana Santos·1h ago
James Wright·1h ago
